Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin

Journal of Clinical Oncology

Volumn 15, Issue 4, 1997, Pages 1432-1438

  Patt, Y Z ^a   Hoque, A ^a   Lozano, R ^a   Pazdur, R ^a   Chase, J ^a   Carrasco, H ^a   Chuang, V ^a   Delpassand, E S ^a   Ellis, L ^a   Curley, S ^a   Roh, M ^a   Jones Jr , D V ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; BILIRUBIN; CARCINOEMBRYONIC ANTIGEN; DEXAMETHASONE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; LACTATE DEHYDROGENASE; RECOMBINANT ALPHA2B INTERFERON;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COLORECTAL CANCER; FEMALE; HEPATIC ARTERY; HUMAN; HUMAN TISSUE; INFUSION PUMP; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; MALE; MUCOSA INFLAMMATION; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0031003461     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.4.1432     Document Type: Article

References (29)

1. Wingo PA, Boldens TT: Cancer statistics 1995. Cancer J Clin 45:8-30, 1995
2. Weiss L, Grundman E, Torhorst J, et al: Hemogenous metastatic patterns in colonic carcinomas: An analysis of 1541 necropsies. J Pathol 150:195-203, 1986
3. Kemeny N, Daly J, Reichman B: Intrahepatic or systemic infusion of floxuridine in patients with liver metastases from colorectal carcinoma: A randomized trial. Ann Intern Med 107:459-465, 1987
4. Hohn DC, Stagg RJ, Friedman MA, et al: A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group trial. J Clin Oncol 7:1646-1654, 1989
5. Chang AE, Schneider PD, Sugarbaker PH, et al: A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206:685-693, 1987
6. Martin JK Jr, O'Connell MJ, Wieand HS, et al: Intra-arterial floxuridine vs systemic flourouracil for hepatic metastases from colorectal cancer: A randomized trial. Arch Surg 125:1022-1027, 1990
7. Rougier P, Laplanche A, Huguier M, et al: Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial. J Clin Oncol 7:1112-1118, 1992
8. Allen-Mersh TG, Earlam S, Frody C, et al: Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 344:1255-1260, 1994
9. Abigerges D, Chabot GG, Armand J-P, et al: Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients. J Clin Oncol 13:210-221, 1995
10. Conti JA, Kemeny NE, Saltz LB, et al: Irinotecan is an active agent in the untreated patients with metastatic colorectal cancer. J Clin Oncol 14:709-715, 1996
11. Bugat R, Rougier P, Doullard JY, et al: Efficacy of irinotecan (CPT-11) in patients with metastatic colorectal cancer after progression while receiving a 5FU-based chemotherapy. Proc Am Soc Clin Oncol 14:222, 1995 (abstr)
12. Rougier P, Bugat R: CPT-11 in the treatment of colorectal cancer: Clinical efficacy and safety profile. Semin Oncol 23:34-41, 1996 (suppl 3)
13. Rothenberg ML, Eckardt JR, Kuhn JG, et al: Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer. J Clin Oncol 14:1128-1135, 1996
14. Hohn DC, Rayner AA, Economov JS, et al: Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion. Cancer 57:465-470, 1986
15. Wadler S, Schwartz EL: Chemotherapy for colorectal carcinoma: Observations regarding recent clinical trials using biochemical modulation. J Clin Oncol 13:2676-2677, 1995 (letter)
16. Schuller J, Czejka M, Micksche M, et al: Biomodulation in regional treatment - Pharmacokinetic aspects of intrahepatic 5-fluorouracil in combination with interferon alpha. Reg Cancer Treat 54:167-170, 1992
17. Sidky YA, Borden EC: Inhibition of angiogenesis by interferons: Effects of tumor and lymphocyte induced vascular responses. Cancer Res 47:5155-5161, 1987
18. Michels NA: Blood Supply and Anatomy of the Upper Abdominai Organs. Philadelphia, PA, Lippincott, 1955, pp 152-154, 256-259, 374-375
19. Miller AB, Hoogstraten B, Staquet M, et al: Reporting results of cancer treatment. Cancer 47:207-214, 1981
20. Simon R: Optimal two-stage designs for phase II clinical trials. Control Clin Trial 10:1-10, 1989
21. Kaplan EL, Meier P: Non-parametric estimation from incomplete observation. J Am Stat Assoc 53:457-481, 1958
22. Breedis C, Young C: The blood supply of neoplasms in the liver. Am J Pathol 30:969-974, 1954
23. Ensminger WD, Gyves JW: Clinical pharmacology of hepatic arterial chemotherapy. Semin Oncol 10:176-182, 1983
24. Collins JM: Pharmacologic rationale for regional drug delivery. J Clin Oncol 2:498-504, 1984
25. O'Connell MJ: Is hepatic infusion of chemotherapy effective treatment for liver metastases? No!, in DeVita V, Hellman S, Rosenberg S (eds): Important Advances in Oncology 1992. Philadelphia, PA, Lippincott, 1992, pp 207-227
26. Kemeny N, Seiter K, Conti JA, et al: Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma: New dose schedules and survival update. Cancer 73:1134-1142, 1994
27. Kemeny N, Cohen A, Bertino JR: Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for treatment of hepatic metastases from colorectal carcinoma. Cancer 65:2446-2450, 1989
28. Kemeny N, Conti JA, Cohen A, et al: Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol 12:2288-2295, 1994
29. Meta-Analysis Group in Cancer: Reappraisal of hepatic arterial infusion in the treatment of non-resectable liver metastases from colorectal cancer. J Natl Cancer Inst 88:252-258, 1996